Fu
brick tea is a unique post-fermented dark tea product which
undergoes controlled fermentation by “golden flower”
fungus Eurotium cristatum. This study examined the
effects of Fu brick tea aqueous extract (FTE) to alleviate insulin
resistance, chronic kidney disease (CKD), and its regulatory mechanism
in high fat diet (HFD)-induced obese rats. Sixteen-week administration
of FTE at 400 mg/kg bw in rats significantly antagonized HFD-induced
insulin resistance and CKD with elevations in serum leptin, TC, TG,
LDL-C, blood urea nitrogen, uric acid, and creatinine levels, respectively
(p < 0.05). FTE treatment decreased the glomerular
area, the thickness of basement membrane of renal tubules, and kidney
fibrosis in HFD-fed rats. FTE alleviated insulin resistance through
down-regulation of SIRP-α expression and activation of the insulin
signaling Akt/GLUT4, FoxO1, and mTOR/S6K1 pathways in skeletal muscle.
Furthermore, FTE prevented the HFD-caused kidney dysfunction and lipid
or collagen accumulation, which was accompanied by the inhibition
of GSK-3β phosphorylation and the action of PI3K/Akt and nuclear
accumulation of Nrf2 in kidney. These results indicated that FTE alleviated
insulin resistance and CKD through modulating insulin signal transduction
cascades in skeletal muscle and enhanced the Nrf2 expression in kidney.